# A Study of Thymidylate Synthase Expression in Patients With Non-Small Cell Lung Cancer

> **NCT00887549** · PHASE2 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 70 (actual)

## Conditions studied

- Non-Small Cell Lung Cancer

## Interventions

- **DRUG:** pemetrexed
- **DRUG:** cisplatin

## Key facts

- **NCT ID:** NCT00887549
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2010-07
- **Final completion:** 2011-06
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2012-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00887549

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00887549, "A Study of Thymidylate Synthase Expression in Patients With Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00887549. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*